Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-10-02
1993-05-04
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 514473, A61K 3144, A61K 3135, A61K 3134
Patent
active
052082440
ABSTRACT:
Inhibition of calcium-independent myocardial phospholipase A.sub.2 is shown for compounds of the formula: ##STR1## wherein R and R.sup.1 independently represent hydrogen and halogen, alkyl, alkenyl and alkynyl radicals; R.sup.2 represents aryl, aryloxy, and heteroaryl radicals; and X is 1 or 2.
REFERENCES:
patent: 4602006 (1986-07-01), Krantz et al.
Krafft, G. A. J. Am. Chem. Soc. 103(18):5459-5466 (1981) [CA 95(15) 132580].
Gardner Diane
Waddell Frederick E.
Washington University
LandOfFree
Method of selectively inhibiting calcium-independent myocardial does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of selectively inhibiting calcium-independent myocardial , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of selectively inhibiting calcium-independent myocardial will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1975397